Julianne Bruno
Angel Investor @ Fairmount Funds Management
Boston, United States
Julianne Bruno is a post-ipo equity investor at Fairmount Funds Management in Boston focused on Health Care and Biotechnology. Julianne Bruno is the current Chief Operating Officer of CRISPR Therapeutics. She previously worked at McKinsey and Company as an Engagement Manager. Julianne Bruno attended The Wharton School.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Julianne Bruno invests in
Stages Julianne Bruno invests in
Countries Julianne Bruno invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Health Diagnostics 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The company lead product candidate, GB0139, is an inhaled inhibitor of galectin-3. GB0139 is being developed for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, in which there is high unmet medicalneed. Galecto was founded in 2011, builds on more than 10 years of research centering on the role of galectin-3 and LOXL-2, and the use of modulators of these proteins to treat fibrosis-related diseases and cancer. Combined with a strong patent estate, these assets give Galecto a unique therapeutic platform. | $284.9M / Post-IPO Equity / Nov 10, 2025 |
Co-Investors
Fairmount Funds Management is a Philadelphia-based investment firm.
Fairmount Funds Management Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Peter Harwin
Co-Founder and Managing Member
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Julianne Bruno invest in?
Julianne Bruno invests primarily in Health Care, Biotechnology and Health Diagnostics startups, most often at Post-IPO Equity stage. Most of the 1 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Julianne Bruno?
Public channels for Julianne Bruno include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Julianne Bruno last invest?
The most recent investment recorded for Julianne Bruno closed in Nov 2025. Shizune tracks 1 investment in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
